John D. FitzGerald, MD, PhD research focuses on gout. Dr. FitzGerald is studying the impact of gout on cholesterol and how that relationship impacts atherosclerosis. Dr. FitzGerald, working with the Ozcan lab, has a patent (pending) application that uses a lens-free polarized microscope to identify gout (monosodium urate – MSU) and pseudogout (calcium pyrophosphate– CPP) crystals. In addition to several reviews and editorials on gout, Dr. FitzGerald has been lead author for the American College of Rheumatology Gout Quality Improvement Measures and American College of Rheumatology Gout Guidelines. Dr. FitzGerald is also interested in Quality of Care and patient outcomes research. He has studied the impact of Rheumatology physician supply on patient care, hospital surgical volume on patient outcomes and patient quality of life after joint replacement surgery. Dr. FitzGerald also conducts policy research. Finally, Dr. FitzGerald has led national efforts to ensure quality of care for Musculoskeletal Ultrasound applications in Rheumatology. Dr. FitzGerald received his MD from Tufts University in 1993. He received PhD in Health Services from UCLA in 2005. He completed his medical residency in 1996 and fellowship in Rheumatology in 1999, both at UCLA.
American Board of Internal Medicine, Internal Medicine